In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...

Allied Market Research published a report, titled, "Lipid Nanoparticles Market by Type (Solid Lipid Nanoparticles, ...

Lipid nanoparticles deliver mRNA to insulin-producing beta cells, prompting them to express a protective protein that shields them from autoimmune attack.

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...

University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...

Researchers developed an mRNA delivery system designed to improve embryo implantation. This approach could enhance ART outcomes and address uterine-factor infertility, with pre-clinical studies ...

The tiny fatty capsules that deliver COVID-19 mRNA vaccines into billions of arms may work better when they're a little disorganized. That's the surprising finding from researchers who developed a new ...

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose. (Nanowerk News) In studies in mice, the researchers showed that an mRNA influenza ...

Announced days before a trial, the deal settles a longstanding dispute and avoids what one analyst called a “worst-case ...

Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to ...